← Browse by Condition
Medical Condition

refractory schizophrenia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT03094429 Phase 2, Phase 3
Recruiting

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Enrollment
287 pts
Location
United States
Sponsor
SyneuRx International (Taiwan)...
View Trial →